Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive review of the treatment and management of Charcot spine.

Therapeutic advances in musculoskeletal disease·2021
Same author

Declining Utilization and Inflation-Adjusted Expenditures for Epidural Procedures in Chronic Spinal Pain in the Medicare Population.

Pain physician·2021
Same author

Declining Utilization Patterns of Percutaneous Adhesiolysis Procedures in the Fee-For-Service (FFS) Medicare Population.

Pain physician·2021
Same author

Is Epidural Injection of Sodium Chloride Solution a True Placebo or an Active Control Agent? A Systematic Review and Meta-Analysis.

Pain physician·2021
Same author

Treatment and Management of Twelfth Rib Syndrome: A Best Practices Comprehensive Review.

Pain physician·2021
Same author

Preoperative, Multidisciplinary Clinical Optimization of Patients with Severely Depressed Left Ventricular Ejection Fraction Who Are Undergoing Coronary Artery Bypass Grafting.

Cardiology and therapy·2020
Same journal

An Updated (2026) Best-Evidence Synthesis Appraisal of the Diagnostic Accuracy and Utility of Facet (Zygapophysial) Joint Injections in Chronic Spinal Pain.

Pain physician·2026
Same journal

Updated 2026 Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Pain physician·2026
Same journal

In Errata.

Pain physician·2026
Same journal

In Response to Comment on "BMJ Publications on Interventional Techniques Do Not Meet Appropriateness Criteria of Conducting a Rapid Review: A Comprehensive Review".

Pain physician·2026
Same journal

Comment on "BMJ Publications on Interventional Techniques Do Not Meet Appropriateness Criteria of Conducting a Rapid Review: A Comprehensive Review".

Pain physician·2026
Same journal

In Response to Comment on "Diagnostic Guidance for Chronic Complex Regional Pain Syndrome Type I and Type II from The American Society of Interventional Physicians (ASIPP)".

Pain physician·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
04:42

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

Published on: June 26, 2018

14.5K

Spinal Cord Stimulator Complication Rates: A Single-Institution, 22-Year Study (1999-2021).

Johnson S Ho1, Michael Glicksman2, Kyle Kang3

  • 1Rutgers Robert Wood Johnson Medical School, Department of Anesthesiology, New Brunswick, NJ, USA.

Pain Physician
|December 2, 2024
PubMed
Summary
This summary is machine-generated.

Spinal cord stimulation (SCS) complication rates significantly decreased between 1999-2015 and 2016-2021. This trend suggests improvements in SCS technology and patient management strategies are reducing risks.

Keywords:
adverse eventsbiological complicationsdevice complicationsspinal cord stimulationIncidence rates

More Related Videos

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats
09:39

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats

Published on: July 14, 2020

7.7K
Paradigms of Lower Extremity Electrical Stimulation Training After Spinal Cord Injury
08:07

Paradigms of Lower Extremity Electrical Stimulation Training After Spinal Cord Injury

Published on: February 1, 2018

12.6K

Related Experiment Videos

Last Updated: Jun 6, 2025

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
04:42

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

Published on: June 26, 2018

14.5K
Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats
09:39

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats

Published on: July 14, 2020

7.7K
Paradigms of Lower Extremity Electrical Stimulation Training After Spinal Cord Injury
08:07

Paradigms of Lower Extremity Electrical Stimulation Training After Spinal Cord Injury

Published on: February 1, 2018

12.6K

Area of Science:

  • Neuromodulation
  • Interventional Pain Management
  • Neurosurgery

Background:

  • Spinal cord stimulation (SCS) is a neuromodulation technique used for chronic pain management.
  • While effective, SCS implantation carries inherent risks and potential complications.
  • Understanding complication trends is crucial for optimizing patient safety and treatment outcomes.

Purpose of the Study:

  • To analyze trends in spinal cord stimulation (SCS) complication rates over a 22-year period.
  • To compare complication rates between two distinct patient cohorts: 1999-2015 and 2016-2021.
  • To identify changes in biological and device-related complications over time.

Main Methods:

  • Retrospective cohort study at a single tertiary care academic hospital.
  • Reviewed 519 patients undergoing percutaneous SCS implantation (262 from 1999-2015, 257 from 2016-2021).
  • Collected data on biological and device-related complications, with at least one year of follow-up.

Main Results:

  • Overall SCS complication rates decreased from 38.9% (1999-2015) to 14.0% (2016-2021).
  • Biological complication rates dropped significantly (12.2% vs. 4.3%), as did device complication rates (26.7% vs. 9.7%).
  • Infection was the leading biological complication in the earlier cohort; inadequate pain coverage was the leading device complication.

Conclusions:

  • A statistically significant decrease in both biological and device-related SCS complications was observed in the more recent cohort.
  • Technological advancements and improved mitigation strategies likely contribute to reduced complication rates.
  • Further prospective, multicenter research is needed to validate these findings and establish definitive trends.